Jerusalem Pharmaceuticals Co. Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 10.42 million compared to USD 10.58 million a year ago. Net income was USD 1.13 million compared to USD 0.361339 million a year ago. Basic earnings per share from continuing operations was USD 0.063 compared to USD 0.02 a year ago.
For the six months, sales was USD 20.89 million compared to USD 19.84 million a year ago. Net income was USD 2.44 million compared to USD 1.22 million a year ago. Basic earnings per share from continuing operations was USD 0.136 compared to USD 0.068 a year ago.